Capital International Investors Bristol Myers Squibb CO Transaction History
Capital International Investors
- $488 Billion
- Q1 2025
A detailed history of Capital International Investors transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Capital International Investors holds 66,465,773 shares of BMY stock, worth $3.1 Billion. This represents 0.83% of its overall portfolio holdings.
Number of Shares
66,465,773
Previous 45,866,624
44.91%
Holding current value
$3.1 Billion
Previous $2.59 Billion
56.26%
% of portfolio
0.83%
Previous 0.51%
Shares
13 transactions
Others Institutions Holding BMY
# of Institutions
2,771Shares Held
1.59BCall Options Held
25.8MPut Options Held
23.9M-
Vanguard Group Inc Valley Forge, PA191MShares$8.94 Billion0.22% of portfolio
-
Black Rock Inc. New York, NY159MShares$7.41 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY108MShares$5.04 Billion0.52% of portfolio
-
State Street Corp Boston, MA94.8MShares$4.43 Billion0.24% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA60.6MShares$2.83 Billion0.71% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $99.3B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...